Applying for Mounjaro on the NHS: What the Criteria Actually Mean for You

The decision you're facing: NHS route or private route?

When people ask how to apply for Mounjaro on the NHS, they are usually facing a fork: wait and see whether they qualify, or explore an alternative. Both are legitimate. The NHS route costs nothing in prescription fees, which matters enormously, but it comes with conditions attached. A prescriber can only offer Mounjaro on the NHS if you fall inside one of the cohorts NHS England has activated, and as of summer 2026, those cohorts are still narrow.

The first cohort, live from June 2025, covers adults with a BMI of 40 or above and four or more of the five qualifying conditions: type 2 diabetes, high blood pressure, dyslipidaemia, cardiovascular disease, and obstructive sleep apnoea. The second cohort, activated on 23 June 2026, extends access to adults with a BMI of 35–39.9 who still have four or more of those same five conditions. A third cohort (BMI 40-plus with three qualifying conditions) is planned for around March 2027. If your BMI or condition count sits just outside a current threshold, you may be months away from eligibility through the NHS, if you qualify at all.

Ethnic-background adjustments apply throughout: NICE recommends thresholds 2.5 kg/m² lower for South Asian, Chinese, other Asian, Middle Eastern, Black African, and African-Caribbean backgrounds. Details of how NICE reached these thresholds are set out in NICE's technology appraisal of tirzepatide (TA1026).

What 'applying' through a GP actually looks like

There is no central NHS application form for Mounjaro. The process runs through your GP surgery. From April 2026, GP practices in England can prescribe tirzepatide directly under the updated QOF contract, but that contract is optional, so the first step is confirming whether your own practice is participating. Some surgeries are; many are not yet. If yours is not, you may be referred into a specialist weight management service, which has its own waiting list.

When you speak to your GP, they will check your BMI against current cohort thresholds, confirm your qualifying conditions from your medical records, and assess whether you're suitable for treatment alongside the NHS's required wraparound care programme. That wraparound element (structured diet and activity support) is mandatory on the NHS; it is not optional. If you are approved, your GP will likely start you at the 2.5mg pen, the tolerability starting dose, and review progress before any titration. The NHS rollout detail is covered more fully on our Mounjaro NHS overview page.

One practical note: NHS appointments tend to cluster around certain weeks, and many people find that the timing of a GP conversation (around school holidays, bank holidays, or end-of-month) can push things by several weeks before a review slot appears. Worth keeping in mind if you're planning ahead.

Where the NHS route may not be the right fit right now

If your BMI is 33, or you have two qualifying conditions instead of four, you fall outside the current NHS cohorts entirely. The same is true if your GP surgery has not opted into the QOF contract, or if your local specialist weight management service has a 12-month waiting list. None of that means Mounjaro is unavailable to you, it means the NHS route is unavailable to you at this point.

Private licensed prescribing is the alternative. Under Mounjaro's licensed terms, a private prescriber can assess any adult with a BMI of 30 or above (or 27-plus with at least one weight-related condition) and, if they judge it clinically appropriate, prescribe accordingly. BMI alone is never a guarantee of approval (the prescriber weighs the full picture) but the eligibility window is substantially wider than the NHS cohort criteria. For a sense of what that looks like in practice, our guide to getting Mounjaro walks through both routes side by side.

Cost is a real factor. Private Mounjaro carries a monthly prescription cost that varies by dose and provider, and if you're looking to get more for your money, you can buy a Mounjaro bundle to reduce the per-pen cost across several weeks of treatment. Our honest breakdown of Mounjaro pricing in the UK explains what the market looks like following Eli Lilly's list-price change in September 2025, and what a legitimate price should include. For those wondering whether to pay at all, this page addresses the realistic options.

What a clinical assessment through a regulated pharmacy involves

Whether your route is NHS or private, a prescriber makes the decision, not an algorithm, not a self-service checkout. At nume, a GPhC-registered Independent Prescriber reads every consultation the same day it is submitted. The process includes photo-ID verification, live weight confirmation on video, and a review of your health history. If you're transferring from another provider or requesting a dose increase, evidence of your current treatment is part of that review.

Our pharmacy holds GPhC premises registration 9012878, verifiable directly at the GPhC online register. Medicines are sourced through the licensed UK supply chain. Once approved, orders placed before noon on a working day are dispatched that day with DPD, in plain packaging, and arrive the next working day at no extra charge. There are no subscriptions and no hidden fees. Our clinical team, including the prescribers who review consultations, is introduced on our clinical team page.

The NHS BMI calculator at NHS.uk is a useful starting point if you are not sure where your BMI sits relative to either the NHS cohort thresholds or the private licensing criteria. If the NHS route looks right for you, pursue it, it is the right call for many people. If the waiting time or the criteria make it the wrong fit right now, a free consultation with a regulated prescriber is the next step.